A detailed history of State Of Wyoming transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, State Of Wyoming holds 1,913 shares of BMY stock, worth $111,910. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,913
Previous 5,211 63.29%
Holding current value
$111,910
Previous $216,000 54.63%
% of portfolio
0.01%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $130,798 - $170,671
-3,298 Reduced 63.29%
1,913 $98,000
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $132,221 - $174,072
3,285 Added 170.56%
5,211 $216,000
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $141,876 - $160,860
-2,957 Reduced 60.56%
1,926 $104,000
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $121,684 - $145,203
2,510 Added 105.77%
4,883 $250,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $84,635 - $94,635
-1,462 Reduced 38.12%
2,373 $137,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $261,784 - $290,670
-4,109 Reduced 51.72%
3,835 $245,000
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $11,893 - $13,489
-181 Reduced 2.23%
7,944 $550,000
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $147,437 - $174,586
2,153 Added 36.05%
8,125 $584,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $480 - $284,000
3,696 Added 162.39%
5,972 $424,000
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $1,379 - $1,519
-19 Reduced 0.83%
2,276 $175,000
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $58,406 - $70,034
-950 Reduced 29.28%
2,295 $168,000
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $48,374 - $56,393
902 Added 38.5%
3,245 $202,000
Q3 2021

Feb 14, 2022

BUY
$59.17 - $69.31 $138,635 - $162,393
2,343 New
2,343 $139,000
Q3 2021

Feb 11, 2022

SELL
$59.17 - $69.31 $141,238 - $165,442
-2,387 Closed
0 $0
Q2 2021

Feb 14, 2022

BUY
$61.91 - $67.42 $147,779 - $160,931
2,387 New
2,387 $159,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.